The Net Margin of Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is 13.21%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-03-31 | 13.21% |
| 2024-03-31 | 16.07% |
| 2023-03-31 | 14.29% |
| 2022-03-31 | 14.69% |
| 2021-03-31 | 14.67% |
| 2020-03-31 | 13.31% |
| 2019-03-31 | 13.30% |
| 2018-03-31 | 9.57% |
| 2017-03-31 | 7.70% |
| 2016-03-31 | 5.92% |